{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:41:19Z","timestamp":1793209279961,"version":"4.5.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,12,26]],"date-time":"2014-12-26T00:00:00Z","timestamp":1419552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,12,26]],"date-time":"2014-12-26T00:00:00Z","timestamp":1419552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1038\/leu.2014.351","type":"journal-article","created":{"date-parts":[[2014,12,26]],"date-time":"2014-12-26T07:35:01Z","timestamp":1419579301000},"page":"1004-1017","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":205,"title":["MicroRNAs in B-cell lymphomas: how a complex biology gets more complex"],"prefix":"10.1038","volume":"29","author":[{"given":"K","family":"Musilova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,26]]},"reference":[{"key":"BFleu2014351_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP . MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215\u2013233.","journal-title":"Cell"},{"key":"BFleu2014351_CR2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/B978-0-12-387038-4.00006-9","volume":"99","author":"RM O'Connell","year":"2012","unstructured":"O'Connell RM, Baltimore D . MicroRNAs and hematopoietic cell development. Curr Top Dev Biol 2012; 99: 145\u2013174.","journal-title":"Curr Top Dev Biol"},{"key":"BFleu2014351_CR3","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3109\/10428194.2013.796055","volume":"54","author":"M Mraz","year":"2013","unstructured":"Mraz M, Kipps TJ . MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia. Leuk Lymphoma 2013; 54: 1836\u20131839.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2014351_CR4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2007.10.009","volume":"27","author":"E Vigorito","year":"2007","unstructured":"Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, Kohlhaas S et al. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 2007; 27: 847\u2013859.","journal-title":"Immunity"},{"key":"BFleu2014351_CR5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cell.2008.02.020","volume":"132","author":"SB Koralov","year":"2008","unstructured":"Koralov SB, Muljo SA, Galler GR, Krek A, Chakraborty T, Kanellopoulou C et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 2008; 132: 860\u2013874.","journal-title":"Cell"},{"key":"BFleu2014351_CR6","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1182\/blood-2011-11-394874","volume":"119","author":"M Mraz","year":"2012","unstructured":"Mraz M, Dolezalova D, Plevova K, Kozubik KS, Mayerova V, Cerna K et al. MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia. Blood 2012; 119: 2110\u20132113.","journal-title":"Blood"},{"key":"BFleu2014351_CR7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2012.04.005","volume":"149","author":"MS Ebert","year":"2012","unstructured":"Ebert MS, Sharp PA . Roles for microRNAs in conferring robustness to biological processes. Cell 2012; 149: 515\u2013524.","journal-title":"Cell"},{"key":"BFleu2014351_CR8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/leu.2012.179","volume":"27","author":"F Akbari Moqadam","year":"2013","unstructured":"Akbari Moqadam F, Pieters R, den Boer ML . The hunting of targets: challenge in miRNA research. Leukemia 2013; 27: 16\u201323.","journal-title":"Leukemia"},{"key":"BFleu2014351_CR9","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1182\/blood-2009-08-240101","volume":"115","author":"JA Pulikkan","year":"2010","unstructured":"Pulikkan JA, Dengler V, Peramangalam PS, Peer Zada AA, Muller-Tidow C, Bohlander SK et al. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 2010; 115: 1768\u20131778.","journal-title":"Blood"},{"key":"BFleu2014351_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature07242","volume":"455","author":"D Baek","year":"2008","unstructured":"Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP . The impact of microRNAs on protein output. Nature 2008; 455: 64\u201371.","journal-title":"Nature"},{"key":"BFleu2014351_CR11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman RC, Farh KK, Burge CB, Bartel DP . Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92\u2013105.","journal-title":"Genome Res"},{"key":"BFleu2014351_CR12","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.immuni.2008.04.002","volume":"28","author":"Y Dorsett","year":"2008","unstructured":"Dorsett Y, McBride KM, Jankovic M, Gazumyan A, Thai TH, Robbiani DF et al. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 2008; 28: 630\u2013638.","journal-title":"Immunity"},{"key":"BFleu2014351_CR13","doi-asserted-by":"publisher","first-page":"15524","DOI":"10.1073\/pnas.242606799","volume":"99","author":"GA Calin","year":"2002","unstructured":"Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524\u201315529.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014351_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ccr.2009.11.019","volume":"17","author":"U Klein","year":"2010","unstructured":"Klein U, Lia M, Crespo M, Siegel R, Shen Q, Mo T et al. The DLEU2\/miR-15a\/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 2010; 17: 28\u201340.","journal-title":"Cancer Cell"},{"key":"BFleu2014351_CR15","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","volume":"103","author":"S Volinia","year":"2006","unstructured":"Volinia S, Calin G, Liu C, Ambs S, Cimmino A, Petrocca F et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006; 103: 2257\u20132261.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFleu2014351_CR16","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","volume":"435","author":"L He","year":"2005","unstructured":"He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828\u2013833.","journal-title":"Nature"},{"key":"BFleu2014351_CR17","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1073\/pnas.0602266103","volume":"103","author":"S Costinean","year":"2006","unstructured":"Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N et al. Pre-B cell proliferation and lymphoblastic leukemia\/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci USA 2006; 103: 7024\u20137029.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014351_CR18","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood-2009-05-220814","volume":"114","author":"S Costinean","year":"2009","unstructured":"Costinean S, Sandhu S, Pedersen I, Tili E, Trotta R, Perrotti D et al. Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. Blood 2009; 114: 1374\u20131382.","journal-title":"Blood"},{"key":"BFleu2014351_CR19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature09284","volume":"467","author":"PP Medina","year":"2010","unstructured":"Medina PP, Nolde M, Slack FJ . OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010; 467: 86\u201390.","journal-title":"Nature"},{"key":"BFleu2014351_CR20","doi-asserted-by":"crossref","first-page":"18208","DOI":"10.1073\/pnas.1315365110","volume":"110","author":"SK Sandhu","year":"2013","unstructured":"Sandhu SK, Fassan M, Volinia S, Lovat F, Balatti V, Pekarsky Y et al. B-cell malignancies in microRNA Emu-miR-17~92 transgenic mice. Proc Natl Acad Sci USA 2013; 110: 18208\u201318213.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014351_CR21","doi-asserted-by":"crossref","first-page":"12210","DOI":"10.1073\/pnas.1007186107","volume":"107","author":"U Santanam","year":"2010","unstructured":"Santanam U, Zanesi N, Efanov A, Costinean S, Palamarchuk A, Hagan JP et al. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression. Proc Natl Acad Sci USA 2010; 107: 12210\u201312215.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014351_CR22","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2014-03-559690","volume":"124","author":"B Cui","year":"2014","unstructured":"Cui B, Chen L, Zhang S, Mraz M, Fecteau JF, Yu J et al. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia. Blood 2014; 124: 546\u2013554.","journal-title":"Blood"},{"key":"BFleu2014351_CR23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1182\/blood-2013-09-527234","volume":"124","author":"M Mraz","year":"2014","unstructured":"Mraz M, Chen L, Rassenti LZ, Ghia EM, Li H, Jepsen K et al. miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1. Blood 2014; 124: 84\u201395.","journal-title":"Blood"},{"key":"BFleu2014351_CR24","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1002\/ijc.22800","volume":"121","author":"C Lawrie","year":"2007","unstructured":"Lawrie C, Soneji S, Marafioti T, Cooper C, Palazzo S, Paterson J et al. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer 2007; 121: 1156\u20131161.","journal-title":"Int J Cancer"},{"key":"BFleu2014351_CR25","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2141.2008.07077.x","volume":"141","author":"CH Lawrie","year":"2008","unstructured":"Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Brit J Haematol 2008; 141: 672\u2013675.","journal-title":"Brit J Haematol"},{"key":"BFleu2014351_CR26","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/leu.2010.91","volume":"24","author":"L Di Lisio","year":"2010","unstructured":"Di Lisio L, Gomez-Lopez G, Sanchez-Beato M, Gomez-Abad C, Rodriguez ME, Villuendas R et al. Mantle cell lymphoma: transcriptional regulation by microRNAs. Leukemia 2010; 24: 1335\u20131342.","journal-title":"Leukemia"},{"key":"BFleu2014351_CR27","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1182\/blood-2009-09-243147","volume":"115","author":"JJ Zhao","year":"2010","unstructured":"Zhao JJ, Lin JH, Lwin T, Yang H, Guo JP, Kong W et al. microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 2010; 115: 2630\u20132639.","journal-title":"Blood"},{"key":"BFleu2014351_CR28","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/leu.2008.377","volume":"23","author":"M Mraz","year":"2009","unstructured":"Mraz M, Malinova K, Kotaskova J, Pavlova S, Tichy B, Malcikova J et al. miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities. Leukemia 2009; 23: 1159\u20131163.","journal-title":"Leukemia"},{"key":"BFleu2014351_CR29","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1101\/gad.1565607","volume":"21","author":"D O'Carroll","year":"2007","unstructured":"O'Carroll D, Mecklenbrauker I, Das PP, Santana A, Koenig U, Enright AJ et al. A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev 2007; 21: 1999\u20132004.","journal-title":"Genes Dev"},{"issue":"3","key":"BFleu2014351_CR30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/ejh.12427","volume":"94","author":"Vaclav Seda","year":"2014","unstructured":"Seda V, Mraz M . B cell receptor (BCR) signalling and its crosstalk with other pathways in normal and malignant cells. Eur J Haematol 2014; e-pub ahead of print 1 August 2014 doi:10.1111\/ejh.12427.","journal-title":"European Journal of Haematology"},{"key":"BFleu2014351_CR31","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cell.2008.02.019","volume":"132","author":"A Ventura","year":"2008","unstructured":"Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ et al. Targeted deletion reveals essential and overlapping functions of the miR-17\u223c92 family of miRNA clusters. Cell 2008; 132: 875\u2013886.","journal-title":"Cell"},{"key":"BFleu2014351_CR32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ni1575","volume":"9","author":"C Xiao","year":"2008","unstructured":"Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, Wang J et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 2008; 9: 405\u2013414.","journal-title":"Nat Immunol"},{"key":"BFleu2014351_CR33","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.immuni.2010.11.010","volume":"33","author":"L Belver","year":"2010","unstructured":"Belver L, de Y\u00e9benes VG, Ramiro AR . MicroRNAs prevent the generation of autoreactive antibodies. Immunity 2010; 33: 713\u2013722.","journal-title":"Immunity"},{"key":"BFleu2014351_CR34","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2011-05-355412","volume":"119","author":"S Xu","year":"2012","unstructured":"Xu S, Guo K, Zeng Q, Huo J, Lam KP . The RNase III enzyme Dicer is essential for germinal center B-cell formation. Blood 2012; 119: 767\u2013776.","journal-title":"Blood"},{"key":"BFleu2014351_CR35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.immuni.2010.06.013","volume":"33","author":"DS Rao","year":"2010","unstructured":"Rao DS, O'Connell RM, Chaudhuri AA, Garcia-Flores Y, Geiger TL, Baltimore D . MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity 2010; 33: 48\u201359.","journal-title":"Immunity"},{"key":"BFleu2014351_CR36","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cell.2007.07.021","volume":"131","author":"C Xiao","year":"2007","unstructured":"Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007; 131: 146\u2013159.","journal-title":"Cell"},{"key":"BFleu2014351_CR37","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1073\/pnas.0702409104","volume":"104","author":"B Zhou","year":"2007","unstructured":"Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF . miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci USA 2007; 104: 7080\u20137085.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014351_CR38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/gcc.10186","volume":"37","author":"A van den Berg","year":"2003","unstructured":"van den Berg A, Kroesen BJ, Kooistra K, de Jong D, Briggs J, Blokzijl T et al. High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Gene Chromosome Cancer 2003; 37: 20\u201328.","journal-title":"Gene Chromosome Cancer"},{"key":"BFleu2014351_CR39","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/science.1139253","volume":"316","author":"A Rodriguez","year":"2007","unstructured":"Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR et al. Requirement of bic\/microRNA-155 for normal immune function. Science 2007; 316: 608\u2013611.","journal-title":"Science"},{"key":"BFleu2014351_CR40","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1126\/science.1141229","volume":"316","author":"TH Thai","year":"2007","unstructured":"Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y et al. Regulation of the germinal center response by microRNA-155. Science 2007; 316: 604\u2013608.","journal-title":"Science"},{"key":"BFleu2014351_CR41","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.immuni.2008.03.015","volume":"28","author":"G Teng","year":"2008","unstructured":"Teng G, Hakimpour P, Landgraf P, Rice A, Tuschl T, Casellas R et al. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 2008; 28: 621\u2013629.","journal-title":"Immunity"},{"key":"BFleu2014351_CR42","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1084\/jem.20080579","volume":"205","author":"VG de Yebenes","year":"2008","unstructured":"de Yebenes VG, Belver L, Pisano DG, Gonzalez S, Villasante A, Croce C et al. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J Exp Med 2008; 205: 2199\u20132206.","journal-title":"J Exp Med"},{"key":"BFleu2014351_CR43","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/labinvest.2009.26","volume":"89","author":"LP Tan","year":"2009","unstructured":"Tan LP, Wang M, Robertus JL, Schakel RN, Gibcus JH, Diepstra A et al. miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes. Lab Invest 2009; 89: 708\u2013716.","journal-title":"Lab Invest"},{"key":"BFleu2014351_CR44","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","volume":"12","author":"M Lagos-Quintana","year":"2002","unstructured":"Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T . Identification of tissue-specific microRNAs from mouse. Curr Biol 2002; 12: 735\u2013739.","journal-title":"Curr Biol"},{"key":"BFleu2014351_CR45","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1064921","volume":"294","author":"M Lagos-Quintana","year":"2001","unstructured":"Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T . Identification of novel genes coding for small expressed RNAs. Science 2001; 294: 853\u2013858.","journal-title":"Science"},{"key":"BFleu2014351_CR46","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","volume":"353","author":"GA Calin","year":"2005","unstructured":"Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353: 1793\u20131801.","journal-title":"N Engl J Med"},{"key":"BFleu2014351_CR47","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/carcin\/bgt396","volume":"35","author":"J Kminkova","year":"2014","unstructured":"Kminkova J, Mraz M, Zaprazna K, Navrkalova V, Tichy B, Plevova K et al. Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia. Carcinogenesis 2014; 35: 992\u20131002.","journal-title":"Carcinogenesis"},{"key":"BFleu2014351_CR48","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1073\/pnas.0800121105","volume":"105","author":"GA Calin","year":"2008","unstructured":"Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M et al. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci USA 2008; 105: 5166\u20135171.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014351_CR49","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1182\/blood-2011-09-381814","volume":"119","author":"M Lia","year":"2012","unstructured":"Lia M, Carette A, Tang H, Shen Q, Mo T, Bhagat G et al. Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines. Blood 2012; 119: 2981\u20132990.","journal-title":"Blood"},{"key":"BFleu2014351_CR50","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/10428190902763517","volume":"50","author":"M Mraz","year":"2009","unstructured":"Mraz M, Pospisilova S, Malinova K, Slapak I, Mayer J . MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk Lymphoma 2009; 50: 506\u2013509.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2014351_CR51","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1586\/ehm.12.54","volume":"5","author":"M Mraz","year":"2012","unstructured":"Mraz M, Pospisilova S . MicroRNAs in chronic lymphocytic leukemia: from causality to associations and back. Expert Rev Hematol 2012; 5: 579\u2013581.","journal-title":"Expert Rev Hematol"},{"key":"BFleu2014351_CR52","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","volume":"102","author":"A Cimmino","year":"2005","unstructured":"Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005; 102: 13944\u201313949.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014351_CR53","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1038\/sj.onc.1210436","volume":"26","author":"JL Mott","year":"2007","unstructured":"Mott JL, Kobayashi S, Bronk SF, Gores GJ . mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007; 26: 6133\u20136140.","journal-title":"Oncogene"},{"key":"BFleu2014351_CR54","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1158\/0008-5472.CAN-06-3613","volume":"66","author":"Y Pekarsky","year":"2006","unstructured":"Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 2006; 66: 11590\u201311593.","journal-title":"Cancer Res"},{"key":"BFleu2014351_CR55","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1182\/blood-2008-08-172254","volume":"113","author":"T Zenz","year":"2009","unstructured":"Zenz T, Mohr J, Eldering E, Kater AP, B\u0102\u013dhler A, Kienle D et al. miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood 2009; 113: 3801\u20133808.","journal-title":"Blood"},{"key":"BFleu2014351_CR56","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1182\/blood-2009-07-234823","volume":"115","author":"D Asslaber","year":"2010","unstructured":"Asslaber D, Pinon JD, Seyfried I, Desch P, St\u00f6cher M, Tinhofer I et al. microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia. Blood 2010; 115: 4191\u20134197.","journal-title":"Blood"},{"key":"BFleu2014351_CR57","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1200\/JCO.2011.34.7872","volume":"29","author":"M Trbusek","year":"2011","unstructured":"Trbusek M, Smardova J, Malcikova J, Sebejova L, Dobes P, Svitakova M et al. Missense mutations located in structural p53 DNA-binding motifs are associated with extremely poor survival in chronic lymphocytic leukemia. J Clin Oncol 2011; 29: 2703\u20132708.","journal-title":"J Clin Oncol"},{"key":"BFleu2014351_CR58","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nature05939","volume":"447","author":"L He","year":"2007","unstructured":"He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447: 1130\u20131134.","journal-title":"Nature"},{"key":"BFleu2014351_CR59","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1182\/blood-2011-01-333484","volume":"118","author":"R Visone","year":"2011","unstructured":"Visone R, Veronese A, Rassenti LZ, Balatti V, Pearl DK, Acunzo M et al. miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. Blood 2011; 118: 3072\u20133079.","journal-title":"Blood"},{"key":"BFleu2014351_CR60","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1182\/blood-2012-03-415737","volume":"120","author":"E Tili","year":"2012","unstructured":"Tili E, Michaille JJ, Luo Z, Volinia S, Rassenti LZ, Kipps TJ et al. The downregulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. Blood 2012; 120: 2631\u20132638.","journal-title":"Blood"},{"key":"BFleu2014351_CR61","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jama.2010.1919","volume":"305","author":"M Fabbri","year":"2011","unstructured":"Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, Rossi S et al. Association of a microRNA\/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA 2011; 305: 59\u201367.","journal-title":"JAMA"},{"key":"BFleu2014351_CR62","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1158\/0008-5472.CAN-12-0803","volume":"72","author":"C Baer","year":"2012","unstructured":"Baer C, Claus R, Frenzel LP, Zucknick M, Park YJ, Gu L et al. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microrna expression in chronic lymphocytic leukemia. Cancer Res 2012; 72: 3775\u20133785.","journal-title":"Cancer Res"},{"key":"BFleu2014351_CR63","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1182\/blood-2011-05-351510","volume":"119","author":"D Sampath","year":"2012","unstructured":"Sampath D, Liu C, Vasan K, Sulda M, Puduvalli VK, Wierda WG et al. Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia. Blood 2012; 119: 1162\u20131172.","journal-title":"Blood"},{"key":"BFleu2014351_CR64","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature03677","volume":"435","author":"KA O'Donnell","year":"2005","unstructured":"O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT . c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435: 839\u2013843.","journal-title":"Nature"},{"key":"BFleu2014351_CR65","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1101\/gad.1872909","volume":"23","author":"P Mu","year":"2009","unstructured":"Mu P, Han YC, Betel D, Yao E, Squatrito M, Ogrodowski P et al. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev 2009; 23: 2806\u20132811.","journal-title":"Genes Dev"},{"key":"BFleu2014351_CR66","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1101\/gad.1861409","volume":"23","author":"V Olive","year":"2009","unstructured":"Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C et al. miR-19 is a key oncogenic component of mir-17-92. Genes Dev 2009; 23: 2839\u20132849.","journal-title":"Genes Dev"},{"key":"BFleu2014351_CR67","doi-asserted-by":"crossref","first-page":"e00822","DOI":"10.7554\/eLife.00822","volume":"2","author":"V Olive","year":"2013","unstructured":"Olive V, Sabio E, Bennett MJ, De Jong CS, Biton A, McGann JC et al. A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis. Elife 2013; 2: e00822.","journal-title":"Elife"},{"key":"BFleu2014351_CR68","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/leu.2011.305","volume":"26","author":"E Rao","year":"2012","unstructured":"Rao E, Jiang C, Ji M, Huang X, Iqbal J, Lenz G et al. The miRNA-17\u223c92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K\/AKT pathway activation. Leukemia 2012; 26: 1064\u20131072.","journal-title":"Leukemia"},{"key":"BFleu2014351_CR69","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1182\/blood-2008-07-163907","volume":"113","author":"M Inomata","year":"2009","unstructured":"Inomata M, Tagawa H, Guo YM, Kameoka Y, Takahashi N, Sawada K . MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 2009; 113: 396\u2013402.","journal-title":"Blood"},{"key":"BFleu2014351_CR70","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1582-4934.2008.00628.x","volume":"13","author":"CH Lawrie","year":"2009","unstructured":"Lawrie CH, Chi JX, Taylor S, Tramonti D, Ballabio E, Palazzo S et al. Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma. J Cell Mol Med 2009; 13: 1248\u20131260.","journal-title":"J Cell Mol Med"},{"key":"BFleu2014351_CR71","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/labinvest.2012.129","volume":"92","author":"A Fassina","year":"2012","unstructured":"Fassina A, Marino F, Siri M, Zambello R, Ventura L, Fassan M et al. The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies. Lab Invest 2012; 92: 1574\u20131582.","journal-title":"Lab Invest"},{"key":"BFleu2014351_CR72","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/imr.12054","volume":"253","author":"V Olive","year":"2013","unstructured":"Olive V, Li Q, He L . mir-17-92: a polycistronic oncomir with pleiotropic functions. Immunol Rev 2013; 253: 158\u2013166.","journal-title":"Immunol Rev"},{"key":"BFleu2014351_CR73","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1073\/pnas.0500613102","volume":"102","author":"P Eis","year":"2005","unstructured":"Eis P, Tam W, Sun L, Chadburn A, Li Z, Gomez M et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 2005; 102: 3627\u20133632.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014351_CR74","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2141.2008.07237.x","volume":"142","author":"A Roehle","year":"2008","unstructured":"Roehle A, Hoefig K, Repsilber D, Thorns C, Ziepert M, Wesche K et al. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. Br J Haematol 2008; 142: 732\u2013744.","journal-title":"Br J Haematol"},{"key":"BFleu2014351_CR75","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1182\/blood-2010-05-285064","volume":"117","author":"K Vargova","year":"2011","unstructured":"Vargova K, Curik N, Burda P, Basova P, Kulvait V, Pospisil V et al. MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia. Blood 2011; 117: 3816\u20133825.","journal-title":"Blood"},{"key":"BFleu2014351_CR76","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1182\/blood-2008-10-184077","volume":"113","author":"R Malumbres","year":"2009","unstructured":"Malumbres R, Sarosiek KA, Cubedo E, Ruiz JW, Jiang X, Gascoyne RD et al. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 2009; 113: 3754\u20133764.","journal-title":"Blood"},{"key":"BFleu2014351_CR77","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1158\/1078-0432.CCR-11-0224","volume":"17","author":"AJ Alencar","year":"2011","unstructured":"Alencar AJ, Malumbres R, Kozloski GA, Advani R, Talreja N, Chinichian S et al. MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. Clin Cancer Res 2011; 17: 4125\u20134135.","journal-title":"Clin Cancer Res"},{"key":"BFleu2014351_CR78","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2199-14-24","volume":"14","author":"RC Thompson","year":"2013","unstructured":"Thompson RC, Vardinogiannis I, Gilmore TD . Identification of an NF-kappaB p50\/p65-responsive site in the human MIR155HG promoter. BMC Mol Biol 2013; 14: 24.","journal-title":"BMC Mol Biol"},{"key":"BFleu2014351_CR79","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.1093\/nar\/gkn666","volume":"36","author":"G Gatto","year":"2008","unstructured":"Gatto G, Rossi A, Rossi D, Kroening S, Bonatti S, Mallardo M . Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Nucleic Acids Res 2008; 36: 6608\u20136619.","journal-title":"Nucleic Acids Res"},{"key":"BFleu2014351_CR80","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1074\/jbc.M110.177063","volume":"286","author":"RC Thompson","year":"2011","unstructured":"Thompson RC, Herscovitch M, Zhao I, Ford TJ, Gilmore TD . NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155\/PU.1 pathway. J Biol Chem 2011; 286: 1675\u20131682.","journal-title":"J Biol Chem"},{"key":"BFleu2014351_CR81","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1182\/blood-2011-08-370536","volume":"119","author":"LN Dagan","year":"2012","unstructured":"Dagan LN, Jiang X, Bhatt S, Cubedo E, Rajewsky K, Lossos IS . miR-155 regulates HGAL expression and increases lymphoma cell motility. Blood 2012; 119: 513\u2013520.","journal-title":"Blood"},{"key":"BFleu2014351_CR82","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1073\/pnas.0910667107","volume":"107","author":"D Rai","year":"2010","unstructured":"Rai D, Kim SW, McKeller MR, Dahia PL, Aguiar RC . Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc Natl Acad Sci USA 2010; 107: 3111\u20133116.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014351_CR83","doi-asserted-by":"crossref","first-page":"E1695","DOI":"10.1073\/pnas.1201516109","volume":"109","author":"IA Babar","year":"2012","unstructured":"Babar IA, Cheng CJ, Booth CJ, Liang X, Weidhaas JB, Saltzman WM et al. Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci USA 2012; 109: E1695\u2013E1704.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014351_CR84","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/imr.12057","volume":"253","author":"E Vigorito","year":"2013","unstructured":"Vigorito E, Kohlhaas S, Lu D, Leyland R . miR-155: an ancient regulator of the immune system. Immunol Rev 2013; 253: 146\u2013157.","journal-title":"Immunol Rev"},{"key":"BFleu2014351_CR85","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/QAD.0b013e3283543e0e","volume":"26","author":"DR Thapa","year":"2012","unstructured":"Thapa DR, Bhatia K, Bream JH, D'Souza G, Rinaldo CR, Wolinsky S et al. B-cell activation induced microRNA-21 is elevated in circulating B cells preceding the diagnosis of AIDS-related non-Hodgkin lymphomas. AIDS 2012; 26: 1177\u20131180.","journal-title":"AIDS"},{"key":"BFleu2014351_CR86","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1038\/leu.2012.108","volume":"26","author":"P Rosato","year":"2012","unstructured":"Rosato P, Anastasiadou E, Garg N, Lenze D, Boccellato F, Vincenti S et al. Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2. Leukemia 2012; 26: 2343\u20132352.","journal-title":"Leukemia"},{"key":"BFleu2014351_CR87","doi-asserted-by":"crossref","first-page":"10144","DOI":"10.1073\/pnas.1103735108","volume":"108","author":"X Ma","year":"2011","unstructured":"Ma X, Kumar M, Choudhury SN, Becker Buscaglia LE, Barker JR, Kanakamedala K et al. Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis. Proc Natl Acad Sci USA 2011; 108: 10144\u201310149.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014351_CR88","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4049\/jimmunol.1101563","volume":"189","author":"NA Barnes","year":"2012","unstructured":"Barnes NA, Stephenson S, Cocco M, Tooze RM, Doody GM . BLIMP-1 and STAT3 counterregulate microRNA-21 during plasma cell differentiation. J Immunol 2012; 189: 253\u2013260.","journal-title":"J Immunol"},{"key":"BFleu2014351_CR89","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12185-012-1256-x","volume":"97","author":"H Bai","year":"2013","unstructured":"Bai H, Wei J, Deng C, Yang X, Wang C, Xu R . MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen. Int J Hematol 2013; 97: 223\u2013231.","journal-title":"Int J Hematol"},{"key":"BFleu2014351_CR90","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1182\/blood-2009-06-222794","volume":"114","author":"Y Yamanaka","year":"2009","unstructured":"Yamanaka Y, Tagawa H, Takahashi N, Watanabe A, Guo YM, Iwamoto K et al. Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma\/leukemia. Blood 2009; 114: 3265\u20133275.","journal-title":"Blood"},{"key":"BFleu2014351_CR91","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000346441","volume":"130","author":"L Gu","year":"2013","unstructured":"Gu L, Song G, Chen L, Nie Z, He B, Pan Y et al. Inhibition of miR-21 induces biological and behavioral alterations in diffuse large B-cell lymphoma. Acta Haematol 2013; 130: 87\u201394.","journal-title":"Acta Haematol"},{"key":"BFleu2014351_CR92","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood-2010-01-263889","volume":"116","author":"S Rossi","year":"2010","unstructured":"Rossi S, Shimizu M, Barbarotto E, Nicoloso MS, Dimitri F, Sampath D et al. microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival. Blood 2010; 116: 945\u2013952.","journal-title":"Blood"},{"key":"BFleu2014351_CR93","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1182\/blood-2010-09-308684","volume":"117","author":"A Baraniskin","year":"2011","unstructured":"Baraniskin A, Kuhnhenn J, Schlegel U, Chan A, Deckert M, Gold R et al. Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system. Blood 2011; 117: 3140\u20133146.","journal-title":"Blood"},{"key":"BFleu2014351_CR94","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.molcel.2010.07.023","volume":"39","author":"D Iliopoulos","year":"2010","unstructured":"Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K . STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 2010; 39: 493\u2013506.","journal-title":"Mol Cell"},{"key":"BFleu2014351_CR95","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1158\/1078-0432.CCR-12-3077","volume":"19","author":"A Navarro","year":"2013","unstructured":"Navarro A, Clot G, Prieto M, Royo C, Vegliante MC, Amador V et al. microRNA expression profiles identify subtypes of mantle cell lymphoma with different clinicobiological characteristics. Clin Cancer Res 2013; 19: 3121\u20133129.","journal-title":"Clin Cancer Res"},{"key":"BFleu2014351_CR96","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10120-013-0313-3","volume":"17","author":"M He","year":"2013","unstructured":"He M, Gao L, Zhang S, Tao L, Wang J, Yang J et al. Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL. Gastric Cancer 2013; 17: 431\u2013441.","journal-title":"Gastric Cancer"},{"key":"BFleu2014351_CR97","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1158\/1078-0432.CCR-10-3244","volume":"17","author":"G Zauli","year":"2011","unstructured":"Zauli G, Voltan R, di Iasio MG, Bosco R, Melloni E, Sana ME et al. miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. Clin Cancer Res 2011; 17: 2712\u20132724.","journal-title":"Clin Cancer Res"},{"key":"BFleu2014351_CR98","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/leu.2013.298","volume":"28","author":"J Boysen","year":"2014","unstructured":"Boysen J, Sinha S, Price-Troska T, Warner SL, Bearss DJ, Viswanatha D et al. The tumor suppressor axis p53\/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients. Leukemia 2014; 28: 451\u2013455.","journal-title":"Leukemia"},{"key":"BFleu2014351_CR99","doi-asserted-by":"crossref","first-page":"13421","DOI":"10.1073\/pnas.0801613105","volume":"105","author":"M Yamakuchi","year":"2008","unstructured":"Yamakuchi M, Ferlito M, Lowenstein CJ . miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 2008; 105: 13421\u201313426.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014351_CR100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10238-012-0186-5","volume":"13","author":"L Li","year":"2013","unstructured":"Li L, Yuan L, Luo J, Gao J, Guo J, Xie X . MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. Clin Exp Med 2013; 13: 109\u2013117.","journal-title":"Clin Exp Med"},{"key":"BFleu2014351_CR101","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1182\/blood-2010-10-312231","volume":"117","author":"VJ Craig","year":"2011","unstructured":"Craig VJ, Cogliatti SB, Imig J, Renner C, Neuenschwander S, Rehrauer H et al. Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1. Blood 2011; 117: 6227\u20136236.","journal-title":"Blood"},{"key":"BFleu2014351_CR102","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/nat.2012.0343","volume":"22","author":"M Rizzo","year":"2012","unstructured":"Rizzo M, Mariani L, Cavallini S, Simili M, Rainaldi G . The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation. Nucleic Acid Ther 2012; 22: 283\u2013288.","journal-title":"Nucleic Acid Ther"},{"key":"BFleu2014351_CR103","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1038\/onc.2010.634","volume":"30","author":"E Sotillo","year":"2011","unstructured":"Sotillo E, Laver T, Mellert H, Schelter JM, Cleary MA, McMahon S et al. Myc overexpression brings out unexpected antiapoptotic effects of miR-34a. Oncogene 2011; 30: 2587\u20132594.","journal-title":"Oncogene"},{"key":"BFleu2014351_CR104","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/cas.12156","volume":"104","author":"S Chen","year":"2013","unstructured":"Chen S, Wang Z, Dai X, Pan J, Ge J, Han X et al. Re-expression of microRNA-150 induces EBV-positive Burkitt lymphoma differentiation by modulating c-Myb in vitro. Cancer Sci 2013; 104: 826\u2013834.","journal-title":"Cancer Sci"},{"key":"BFleu2014351_CR105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.immuni.2005.08.005","volume":"23","author":"MD Thomas","year":"2005","unstructured":"Thomas MD, Kremer CS, Ravichandran KS, Rajewsky K, Bender TP . c-Myb is critical for B cell development and maintenance of follicular B cells. Immunity 2005; 23: 275\u2013286.","journal-title":"Immunity"},{"key":"BFleu2014351_CR106","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1182\/blood-2004-03-1209","volume":"104","author":"SL Barrans","year":"2004","unstructured":"Barrans SL, Fenton JA, Banham A, Owen RG, Jack AS . Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome. Blood 2004; 104: 2933\u20132935.","journal-title":"Blood"},{"key":"BFleu2014351_CR107","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10735-005-6521-3","volume":"36","author":"P Brown","year":"2005","unstructured":"Brown P, Marafioti T, Kusec R, Banham AH . The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma. J Mol Histol 2005; 36: 249\u2013256.","journal-title":"J Mol Histol"},{"key":"BFleu2014351_CR108","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1200\/JCO.2006.05.6150","volume":"24","author":"X Sagaert","year":"2006","unstructured":"Sagaert X, de Paepe P, Libbrecht L, Vanhentenrijk V, Verhoef G, Thomas J et al. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma. J Clin Oncol 2006; 24: 2490\u20132497.","journal-title":"J Clin Oncol"},{"key":"BFleu2014351_CR109","doi-asserted-by":"crossref","first-page":"e23114","DOI":"10.1371\/journal.pone.0023114","volume":"6","author":"N Tano","year":"2011","unstructured":"Tano N, Kim HW, Ashraf M . microRNA-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting Cxcr4. PLoS One 2011; 6: e23114.","journal-title":"PLoS One"},{"key":"BFleu2014351_CR110","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/leu.2011.81","volume":"25","author":"A Watanabe","year":"2011","unstructured":"Watanabe A, Tagawa H, Yamashita J, Teshima K, Nara M, Iwamoto K et al. The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia 2011; 25: 1324\u20131334.","journal-title":"Leukemia"},{"key":"BFleu2014351_CR111","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jaci.2013.04.048","volume":"132","author":"K Bryniarski","year":"2013","unstructured":"Bryniarski K, Ptak W, Jayakumar A, Pullmann K, Caplan MJ, Chairoungdua A et al. Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. J Allergy Clin Immunol 2013; 132: 170\u2013181.","journal-title":"J Allergy Clin Immunol"},{"key":"BFleu2014351_CR112","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ccr.2012.08.028","volume":"22","author":"X Jiang","year":"2012","unstructured":"Jiang X, Huang H, Li Z, Li Y, Wang X, Gurbuxani S et al. Blockade of miR-150 maturation by MLL-fusion\/MYC\/LIN-28 is required for MLL-associated leukemia. Cancer Cell 2012; 22: 524\u2013535.","journal-title":"Cancer Cell"},{"key":"BFleu2014351_CR113","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","volume":"351","author":"SS Dave","year":"2004","unstructured":"Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004; 351: 2159\u20132169.","journal-title":"N Engl J Med"},{"key":"BFleu2014351_CR114","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2141.2011.08794.x","volume":"155","author":"M Mraz","year":"2011","unstructured":"Mraz M, Zent CS, Church AK, Jelinek DF, Wu X, Pospisilova S et al. Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin \u03b1-4-\u03b2-1 (VLA-4) with natalizumab can overcome this resistance. Br J Haematol 2011; 155: 53\u201364.","journal-title":"Br J Haematol"},{"key":"BFleu2014351_CR115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/leu.2010.230","volume":"25","author":"J Lin","year":"2011","unstructured":"Lin J, Lwin T, Zhao JJ, Tam W, Choi YS, Moscinski LC et al. Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas. Leukemia 2011; 25: 145\u2013152.","journal-title":"Leukemia"},{"key":"BFleu2014351_CR116","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1182\/blood-2010-03-275925","volume":"116","author":"T Lwin","year":"2010","unstructured":"Lwin T, Lin J, Choi YS, Zhang X, Moscinski LC, Wright KL et al. Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a. Blood 2010; 116: 5228\u20135236.","journal-title":"Blood"},{"key":"BFleu2014351_CR117","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1172\/JCI64210","volume":"123","author":"T Lwin","year":"2013","unstructured":"Lwin T, Zhao X, Cheng F, Zhang X, Huang A, Shah B et al. A microenvironment-mediated c-Myc\/miR-548m\/HDAC6 amplification loop in non-Hodgkin B cell lymphomas. J Clin Invest 2013; 123: 4612\u20134626.","journal-title":"J Clin Invest"},{"key":"BFleu2014351_CR118","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1182\/blood-2012-12-473090","volume":"122","author":"JN Psathas","year":"2013","unstructured":"Psathas JN, Doonan PJ, Raman P, Freedman BD, Minn AJ, Thomas-Tikhonenko A . The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop. Blood 2013; 122: 4220\u20134229.","journal-title":"Blood"},{"key":"BFleu2014351_CR119","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrd4359","volume":"13","author":"Z Li","year":"2014","unstructured":"Li Z, Rana TM . Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov 2014; 13: 622\u2013638.","journal-title":"Nat Rev Drug Discov"},{"key":"BFleu2014351_CR120","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","volume":"368","author":"HL Janssen","year":"2013","unstructured":"Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013; 368: 1685\u20131694.","journal-title":"N Engl J Med"},{"key":"BFleu2014351_CR121","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fgene.2012.00120","volume":"3","author":"AG Bader","year":"2012","unstructured":"Bader AG . miR-34\u2014a microRNA replacement therapy is headed to the clinic. Front Genet 2012; 3: 120.","journal-title":"Front Genet"},{"key":"BFleu2014351_CR122","volume-title":"A Phase 1 study of first-in-class microRNA-34 mimic, MRX34, in patients with hepatocellular carcinoma or advanced cancer with liver metastasis (Late Breaking Abstract, 4LBA)","author":"MBA Beg","year":"2014","unstructured":"Beg MBA, Sachdev J, Borad M, Cortes J, Tibes R, Kang Y et al. A Phase 1 study of first-in-class microRNA-34 mimic, MRX34, in patients with hepatocellular carcinoma or advanced cancer with liver metastasis (Late Breaking Abstract, 4LBA). 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics: Barcelona, Spain, 2014."},{"key":"BFleu2014351_CR123","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1038\/leu.2012.110","volume":"26","author":"VJ Craig","year":"2012","unstructured":"Craig VJ, Tzankov A, Flori M, Schmid CA, Bader AG, Muller A . Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo. Leukemia 2012; 26: 2421\u20132424.","journal-title":"Leukemia"},{"key":"BFleu2014351_CR124","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1158\/1078-0432.CCR-12-1708","volume":"18","author":"MT Di Martino","year":"2012","unstructured":"Di Martino MT, Leone E, Amodio N, Foresta U, Lionetti M, Pitari MR et al. Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence. Clin Cancer Res 2012; 18: 6260\u20136270.","journal-title":"Clin Cancer Res"},{"key":"BFleu2014351_CR125","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1158\/1535-7163.MCT-09-0127","volume":"8","author":"E Salerno","year":"2009","unstructured":"Salerno E, Scaglione BJ, Coffman FD, Brown BD, Baccarini A, Fernandes H et al. Correcting miR-15a\/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity. Mol Cancer Ther 2009; 8: 2684\u20132692.","journal-title":"Mol Cancer Ther"},{"key":"BFleu2014351_CR126","first-page":"2933","volume":"9","author":"S Arora","year":"2014","unstructured":"Arora S, Swaminathan SK, Kirtane A, Srivastava SK, Bhardwaj A, Singh S et al. Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy. Int J Nanomedicine 2014; 9: 2933\u20132942.","journal-title":"Int J Nanomedicine"},{"key":"BFleu2014351_CR127","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1182\/blood-2012-02-410647","volume":"120","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Roccaro AM, Rombaoa C, Flores L, Obad S, Fernandes SM et al. LNA-mediated anti-microRNA-155 silencing in low-grade B cell lymphomas. Blood 2012; 120: 1678\u20131686.","journal-title":"Blood"},{"key":"BFleu2014351_CR128","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13045-014-0079-z","volume":"7","author":"S Dereani","year":"2014","unstructured":"Dereani S, Macor P, D'Agaro T, Mezzaroba N, Dal-Bo M, Capolla S et al. Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemia. J Hematol Oncol 2014; 7: 79.","journal-title":"J Hematol Oncol"},{"key":"BFleu2014351_CR129","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1182\/blood-2010-10-316034","volume":"117","author":"DC Spierings","year":"2011","unstructured":"Spierings DC, McGoldrick D, Hamilton-Easton AM, Neale G, Murchison EP, Hannon GJ et al. Ordered progression of stage-specific miRNA profiles in the mouse B2 B-cell lineage. Blood 2011; 117: 5340\u20135349.","journal-title":"Blood"},{"key":"BFleu2014351_CR130","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1182\/blood-2010-05-285403","volume":"116","author":"DD Jima","year":"2010","unstructured":"Jima DD, Zhang J, Jacobs C, Richards KL, Dunphy CH, Choi WW et al. Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood 2010; 116: e118\u2013e127.","journal-title":"Blood"},{"key":"BFleu2014351_CR131","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2008-03-142182","volume":"112","author":"RW Chen","year":"2008","unstructured":"Chen RW, Bemis LT, Amato CM, Myint H, Tran H, Birks DK et al. Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. Blood 2008; 112: 822\u2013829.","journal-title":"Blood"},{"key":"BFleu2014351_CR132","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1182\/blood-2008-11-189407","volume":"113","author":"B Stamatopoulos","year":"2009","unstructured":"Stamatopoulos B, Meuleman N, Haibe-Kains B, Saussoy P, Van Den Neste E, Michaux L et al. microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood 2009; 113: 5237\u20135245.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2014351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2014351","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2014351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:12:58Z","timestamp":1648743178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2014351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,26]]},"references-count":132,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["BFleu2014351"],"URL":"https:\/\/doi.org\/10.1038\/leu.2014.351","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,26]]},"assertion":[{"value":"24 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}